<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font6" size="9" family="GillSans,BoldItalic" color="#000000"/>
<text top="41" left="55" width="219" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Cost Effectiveness and Resource Allocation 2006, 4 :17<i>Cost Effectiveness and Resource Allocation</i></text>
<text top="41" left="355" width="199" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.resource-allocation.com/content/4/1/17</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t3" reading_order_no="105" segment_no="14" tag_type="text">Page 2 of 8<b>4</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="106" segment_no="15" tag_type="text">(page number not for citation purposes)</text>
<text top="87" left="55" width="241" height="9" font="font4" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="text">pled with the aging of the population, analysts predict</text>
<text top="98" left="55" width="241" height="9" font="font4" id="p1_t6" reading_order_no="3" segment_no="2" tag_type="text">that COPD will account for an increased proportion of</text>
<text top="110" left="55" width="241" height="9" font="font4" id="p1_t7" reading_order_no="4" segment_no="2" tag_type="text">deaths in the near future [2]. With respect to morbidity,<i>(page number not for citation purposes)</i></text>
<text top="122" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="2" tag_type="text">COPD impairs both functional status and quality of life</text>
<text top="134" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="6" segment_no="2" tag_type="text">[1]. Economically, the costs of COPD associated with</text>
<text top="145" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="7" segment_no="2" tag_type="text">medical care and lost productivity are staggering, exceed-<a href="">ture [2]. With</a> respect to morbidity,</text>
<text top="157" left="55" width="205" height="9" font="font4" id="p1_t11" reading_order_no="8" segment_no="2" tag_type="text">ing $37 billion annually in the United States [3].</text>
<text top="181" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="9" segment_no="6" tag_type="text">Anemia is commonly present among individuals with<a href="">[1]. Eco</a>nomically, the costs of COPD associated with</text>
<text top="192" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="10" segment_no="6" tag_type="text">chronic illnesses. In a broad range of medical conditions,</text>
<text top="204" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="11" segment_no="6" tag_type="text">concomitant anemia is increasingly being recognized as a<a href="">3</a>].</text>
<text top="216" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="12" segment_no="6" tag_type="text">risk factor associated with increased mortality [4,5]. There</text>
<text top="228" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="13" segment_no="6" tag_type="text">is also growing evidence of increased health care utiliza-</text>
<text top="239" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="14" segment_no="6" tag_type="text">tion and costs associated with anemia in disease states</text>
<text top="251" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="15" segment_no="6" tag_type="text">such as chronic kidney disease, HIV, rheumatoid arthritis,<a href="">ality [4,5]. </a>There</text>
<text top="263" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="6" tag_type="text">inflammatory bowel disease, congestive heart failure, and</text>
<text top="275" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="6" tag_type="text">cancer [6-8]. However, less is known regarding the impact</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="18" segment_no="6" tag_type="text">of anemia on mortality, morbidity, and costs of care for</text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="19" segment_no="6" tag_type="text">patients with COPD. Cote and colleagues observed that</text>
<text top="310" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="20" segment_no="6" tag_type="text">anemia was associated not only with increased mortality<a href="">ncer [6-8]. Howe</a>ver, less is known regarding the impact</text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="21" segment_no="6" tag_type="text">but also with worsened dyspnea scores and functional</text>
<text top="333" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="22" segment_no="6" tag_type="text">capacity as measured by the 6-minute walking distance in</text>
<text top="345" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="23" segment_no="6" tag_type="text">a COPD cohort [9,10]. The effect of anemia was inde-</text>
<text top="357" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="24" segment_no="6" tag_type="text">pendent of age, forced expiratory volume in one second,</text>
<text top="369" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="25" segment_no="6" tag_type="text">and functional status. Similarly, a review of a French</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="26" segment_no="6" tag_type="text">national database indicated that subjects with severe oxy-<a href="">hort [9,10]</a>. The effect of anemia was inde-</text>
<text top="392" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="27" segment_no="6" tag_type="text">gen-dependent COPD and anemia experienced an</text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t31" reading_order_no="28" segment_no="6" tag_type="text">increased risk of hospitalization and short-term mortality</text>
<text top="416" left="55" width="171" height="9" font="font4" id="p1_t32" reading_order_no="29" segment_no="6" tag_type="text">compared to those without anemia [11].</text>
<text top="439" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="30" segment_no="8" tag_type="text">Despite the growing awareness of an association between</text>
<text top="451" left="55" width="241" height="9" font="font4" id="p1_t34" reading_order_no="31" segment_no="8" tag_type="text">worse clinical and functional outcomes and anemia in</text>
<text top="463" left="55" width="241" height="9" font="font4" id="p1_t35" reading_order_no="32" segment_no="8" tag_type="text">COPD patients, the financial implications of anemia in<a href="">[11]</a>.</text>
<text top="474" left="55" width="241" height="9" font="font4" id="p1_t36" reading_order_no="33" segment_no="8" tag_type="text">COPD have not been examined previously. To determine</text>
<text top="486" left="55" width="241" height="9" font="font4" id="p1_t37" reading_order_no="34" segment_no="8" tag_type="text">what incremental costs, if any, were associated with ane-</text>
<text top="498" left="55" width="241" height="9" font="font4" id="p1_t38" reading_order_no="35" segment_no="8" tag_type="text">mia in COPD patients, and to confirm the association of</text>
<text top="510" left="55" width="241" height="9" font="font4" id="p1_t39" reading_order_no="36" segment_no="8" tag_type="text">anemia with clinical and functional outcomes in a larger</text>
<text top="521" left="55" width="241" height="9" font="font4" id="p1_t40" reading_order_no="37" segment_no="8" tag_type="text">population, data from Medicare beneficiaries in the</text>
<text top="533" left="55" width="120" height="9" font="font4" id="p1_t41" reading_order_no="38" segment_no="8" tag_type="text">United States were analyzed.</text>
<text top="557" left="55" width="43" height="10" font="font5" id="p1_t42" reading_order_no="39" segment_no="9" tag_type="title">Methods</text>
<text top="569" left="55" width="147" height="9" font="font6" id="p1_t43" reading_order_no="40" segment_no="10" tag_type="title">Overview and database description</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t44" reading_order_no="41" segment_no="11" tag_type="text">Medicare claims data for persons with COPD were ana-</text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t45" reading_order_no="42" segment_no="11" tag_type="text">lyzed; costs and outcomes for patients with anemia were<b>Methods</b></text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t46" reading_order_no="43" segment_no="11" tag_type="text">compared to those of patients without anemia. The data<i><b>Overview and database description</b></i></text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t47" reading_order_no="44" segment_no="11" tag_type="text">source was the Medicare 5% beneficiary encrypted files</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t48" reading_order_no="45" segment_no="11" tag_type="text">(BEF) from a recent five-year period (1997–2001), availa-</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t49" reading_order_no="46" segment_no="11" tag_type="text">ble from the Centers for Medicare and Medicaid Services</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t50" reading_order_no="47" segment_no="11" tag_type="text">(CMS). The BEF represents a systematic 5% sample of all</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t51" reading_order_no="48" segment_no="11" tag_type="text">Medicare enrollees, which corresponds to essentially all</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t52" reading_order_no="49" segment_no="11" tag_type="text">U.S. residents age 65 and older as well as select groups</text>
<text top="686" left="55" width="241" height="9" font="font4" id="p1_t53" reading_order_no="50" segment_no="11" tag_type="text">younger than age 65 (e.g., patients with end-stage renal</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t54" reading_order_no="51" segment_no="11" tag_type="text">disease or certain disabilities). This analysis included all</text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t55" reading_order_no="52" segment_no="11" tag_type="text">categories of the BEF data: Durable Medical Equipment</text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t56" reading_order_no="53" segment_no="11" tag_type="text">(DME), Inpatient Facility, Hospice, Outpatient Facility,</text>
<text top="87" left="313" width="241" height="9" font="font4" id="p1_t57" reading_order_no="54" segment_no="3" tag_type="text">Home Health Agency (HHA), Skilled Nursing Facility</text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="55" segment_no="3" tag_type="text">(SNF, nursing home), and Physician/Supplier (Part B)</text>
<text top="110" left="313" width="30" height="9" font="font4" id="p1_t59" reading_order_no="56" segment_no="3" tag_type="text">claims.</text>
<text top="134" left="313" width="98" height="9" font="font6" id="p1_t60" reading_order_no="57" segment_no="4" tag_type="title">Subjects and definitions</text>
<text top="145" left="313" width="241" height="9" font="font4" id="p1_t61" reading_order_no="58" segment_no="5" tag_type="text">To be included in the cohort, beneficiaries had to have at</text>
<text top="157" left="313" width="241" height="9" font="font4" id="p1_t62" reading_order_no="59" segment_no="5" tag_type="text">least two claims with diagnoses (primary or secondary) of</text>
<text top="169" left="313" width="241" height="9" font="font4" id="p1_t63" reading_order_no="60" segment_no="5" tag_type="text">COPD from either Part B (physician/supplier) or outpa-<i><b>Subjects and definitions</b></i></text>
<text top="181" left="313" width="241" height="9" font="font4" id="p1_t64" reading_order_no="61" segment_no="5" tag_type="text">tient files. Persons under 65 years of age were excluded in</text>
<text top="192" left="313" width="241" height="9" font="font4" id="p1_t65" reading_order_no="62" segment_no="5" tag_type="text">order to limit the impact of age as a source of heterogene-</text>
<text top="204" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="63" segment_no="5" tag_type="text">ity in the study population. Those persons who were not</text>
<text top="216" left="313" width="241" height="9" font="font4" id="p1_t67" reading_order_no="64" segment_no="5" tag_type="text">residents of either one of the 50 states or the District of</text>
<text top="228" left="313" width="241" height="9" font="font4" id="p1_t68" reading_order_no="65" segment_no="5" tag_type="text">Columbia were also excluded. In addition, those with</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="66" segment_no="5" tag_type="text">known nutritional or hereditary anemias or with other</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="67" segment_no="5" tag_type="text">disease states that are commonly associated with anemia</text>
<text top="263" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="68" segment_no="5" tag_type="text">(end stage renal disease, cancer, and gastrointestinal</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t72" reading_order_no="69" segment_no="5" tag_type="text">bleeding) were eliminated. COPD patients with co-mor-</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t73" reading_order_no="70" segment_no="5" tag_type="text">bid anemia were identified in two ways: claims with ICD-</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t74" reading_order_no="71" segment_no="5" tag_type="text">9 codes specific for anemia, or receipt of blood transfu-</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t75" reading_order_no="72" segment_no="5" tag_type="text">sions not associated with other apparent causes (e.g.,</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t76" reading_order_no="73" segment_no="5" tag_type="text">acute blood loss from surgery, trauma, etc.). The appendix</text>
<text top="333" left="313" width="241" height="9" font="font4" id="p1_t77" reading_order_no="74" segment_no="5" tag_type="text">lists the specific ICD-9 codes used to identify and define</text>
<text top="345" left="313" width="71" height="9" font="font4" id="p1_t78" reading_order_no="75" segment_no="5" tag_type="text">the study cohort.</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t79" reading_order_no="76" segment_no="7" tag_type="text">To control for variation in the utilization of medical care</text>
<text top="380" left="313" width="241" height="9" font="font4" id="p1_t80" reading_order_no="77" segment_no="7" tag_type="text">services over time and the inherent inter-patient variabil-</text>
<text top="392" left="313" width="241" height="9" font="font4" id="p1_t81" reading_order_no="78" segment_no="7" tag_type="text">ity in the need for healthcare encounters, an "index date"</text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t82" reading_order_no="79" segment_no="7" tag_type="text">was determined for each patient. For those with COPD</text>
<text top="416" left="313" width="241" height="9" font="font4" id="p1_t83" reading_order_no="80" segment_no="7" tag_type="text">but without anemia, the date of the first medical claim</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t84" reading_order_no="81" segment_no="7" tag_type="text">with a COPD diagnosis at least six months after entering</text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t85" reading_order_no="82" segment_no="7" tag_type="text">the database (at the time of either Medicare enrollment or</text>
<text top="451" left="313" width="241" height="9" font="font4" id="p1_t86" reading_order_no="83" segment_no="7" tag_type="text">the start of the data set's availability) served as the index</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t87" reading_order_no="84" segment_no="7" tag_type="text">date. For their anemic counterparts, the index date was the</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t88" reading_order_no="85" segment_no="7" tag_type="text">first medical claim with a COPD diagnosis that was both</text>
<text top="486" left="313" width="241" height="9" font="font4" id="p1_t89" reading_order_no="86" segment_no="7" tag_type="text">six months after that patient entered the data set and after</text>
<text top="498" left="313" width="241" height="9" font="font4" id="p1_t90" reading_order_no="87" segment_no="7" tag_type="text">or concurrent with the claim for anemia. Only patients</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t91" reading_order_no="88" segment_no="7" tag_type="text">with at least six months of Medicare enrollment prior to</text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t92" reading_order_no="89" segment_no="7" tag_type="text">their index date and at least 12 months of enrollment fol-</text>
<text top="533" left="313" width="241" height="9" font="font4" id="p1_t93" reading_order_no="90" segment_no="7" tag_type="text">lowing their index date were included in the analysis.</text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t94" reading_order_no="91" segment_no="7" tag_type="text">Details regarding selection of case and control patients are</text>
<text top="557" left="313" width="92" height="9" font="font4" id="p1_t95" reading_order_no="92" segment_no="7" tag_type="text">illustrated in Figure 1.</text>
<text top="580" left="313" width="80" height="9" font="font6" id="p1_t96" reading_order_no="93" segment_no="12" tag_type="title">Outcome measures</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t97" reading_order_no="94" segment_no="13" tag_type="text">Costs to the Medicare system for all medical care served as</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t98" reading_order_no="95" segment_no="13" tag_type="text">the primary endpoint. To determine the attributable effect<a href=""> 1.</a></text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t99" reading_order_no="96" segment_no="13" tag_type="text">of anemia, costs among persons with anemia and COPD<i><b>Outcome measures</b></i></text>
<text top="627" left="313" width="241" height="9" font="font4" id="p1_t100" reading_order_no="97" segment_no="13" tag_type="text">were compared to costs among non-anemic COPD</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t101" reading_order_no="98" segment_no="13" tag_type="text">patients. Costs of care were stratified by the type of service</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t102" reading_order_no="99" segment_no="13" tag_type="text">involved (e.g., durable medical equipment, inpatient</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t103" reading_order_no="100" segment_no="13" tag_type="text">facility, hospice, etc.). Costs based on claims (submitted</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t104" reading_order_no="101" segment_no="13" tag_type="text">charges) and actual payments (reimbursements) were</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t105" reading_order_no="102" segment_no="13" tag_type="text">analyzed separately. All costs were inflated to 2004 U.S.</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t106" reading_order_no="103" segment_no="13" tag_type="text">dollars by using the medical care component of the Con-</text>
<text top="709" left="313" width="78" height="9" font="font4" id="p1_t107" reading_order_no="104" segment_no="13" tag_type="text">sumer Price Index.</text>
</page>
</pdf2xml>
